Broad markets, although continuing to trend higher, are showing signs of increasing volatility and uncertainty. While there has been a strong rally in stocks since the sharp correction earlier in the month, there is something peculiar happening under the surface. Defensive sectors and stocks are making new highs, while the former leaders hover below. While I have long been encouraging investors join in the mega cap technology and artificial intelligence rally for the long-term, I also noted that the period ...

Wall Street has been maintaining its northbound journey in the second half of 2024 after an impressive first half. U.S. stock markets' rally, which started at the beginning of 2023 is showing no signs of declining barring some minor fluctuations. The rally is likely to gather pace over the remaining months this year as an interest rate cut in September is now almost certain. Under this circumstance, it should be prudent for investors to put money in those stocks with strong momentum. Here we are recommendin ...

Have you been paying attention to shares of DaVita HealthCare (DVA) ? Shares have been on the move with the stock up 6.6% over the past month. The stock hit a new 52-week high of $151.05 in the previous session. DaVita HealthCare has gained 42.1% since the start of the year compared to the 8.6% move for the Zacks Medical sector and the 11.4% return for the Zacks Medical - Outpatient and Home Healthcare industry. What's Driving the Outperformance? The stock has an impressive record of positive earnings surpr ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades. While many investors like to look for momen ...

DENVER, Aug. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today the pricing of its previously announced private offering (the "offering") of $1.0 billion aggregate principal amount of its 6.875% senior notes due 2032 (the "2032 notes"). The 2032 notes were priced at 100.000% of their face amount to yield a 6.875% coupon. The offering is expected to close on August 13, 2024, subject to satisfaction of customary closing conditions. DaVita intends to use the net proceeds from the offeri ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use a variety of methods, including tried-and-true valuation met ...

DENVER, Aug. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private offering (the "offering") of $1.0 billion aggregate principal amount of its senior notes due 2032 (the "2032 notes"), subject to market and other conditions. DaVita intends to use the net proceeds from the offering to (i) repay a portion of its outstanding Term Loan B-1 facility borrowings maturing in 2026 and a portion of its outstanding revolving credit facility borrowings, in each case, ...

DaVita Inc. (DVA) delivered adjusted earnings per share (EPS) of $2.59 in the second quarter of 2024, up 24.5% year over year. The figure topped the Zacks Consensus Estimate by 4.9%. GAAP EPS for the quarter was $2.50, reflecting a surge of 30.9% year over year. Revenues in Detail Revenues of $3.19 billion in the second quarter increased 6.2% year over year. The figure surpassed the Zacks Consensus Estimate by 0.7%. Per management, the revenue uptick primarily resulted from a seasonal improvement from patie ...

DaVita Inc. (NYSE:DVA) Q2 2024 Earnings Conference Call August 6, 2024 5:00 PM ET Company Participants Nic Eliason - Group Vice President, Investor Relations Javier Rodriguez - Chief Executive Officer Joel Ackerman - Chief Financial Officer Conference Call Participants Pito Chickering - Deutsche Bank Justin Lake - Wolfe Research AJ Rice - UBS Andrew Mok - Barclays Ryan Langston - TD Cowen Operator Good evening. My name is Michelle, and I will be your conference facilitator today. At this time, I would like ...

DaVita HealthCare (DVA) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.47 per share. This compares to earnings of $2.08 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 4.86%. A quarter ago, it was expected that this kidney dialysis provider would post earnings of $1.96 per share when it actually produced earnings of $2.38, delivering a surprise of 21.43%. Over the last four qua ...